| Subcribe via RSS



Biotech on life support

July 16th, 2007

When QLT Inc. announced last week that a U.S. court had ordered the Vancouver-based biotechnology company to pay royalties for all past, present and future sales of its marquee drug to a Massachusetts specialty hospital, its stock, naturally, took a hit.

Original post by Canada.com


(click on the author/publication link above to see full post)
This entry was posted on Monday, July 16th, 2007 at 3:00 am. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.

«
»